CXCL12 and type 1 diabetes mellitus: These findings highlight the complexity of the CXCL12/CXCR4 axis, which can contribute to disease pathogenesis in SLE and offer therapeutic benefits in T1D, suggesting that blanket targeting of this axis may not be universally beneficial.